HC Wainwright & Co. Maintains Buy on Corcept Therapeutics, Lowers Price Target to $28
HC Wainwright & Co. Maintains Buy on Corcept Therapeutics, Lowers Price Target to $28
HC Wainwright & Co.維持對Corcept Therapeutics的買入，將目標股價下調至28美元
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and lowers the price target from $34 to $28.
HC Wainwright & Co. 分析師Swayampakula Ramakanth維持Corcept Therapeutics（納斯達克股票代碼：CORT）的買入並將目標股價從34美元下調至28美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。